All Updates

All Updates

icon
Filter
Partnerships
Massive Bio and Mika Health partner to expand psycho-oncology and clinical trial services across US and Europe
Clinical Trial Technology
Jun 2, 2024
This week:
M&A
Funding
TravelPerk raises USD 135 million in debt funding for expansion; acquires AmTrav
Travel Tech
Yesterday
Product updates
Apple announces Apple Pay Later shutdown
Buy Now, Pay Later
Jun 17, 2024
Management news
Velo3D appoints Brad Kreger as permanent CEO
Additive Manufacturing
Jun 17, 2024
Partnerships
Perplexity partners with SoftBank for AI search engine promotion in Japan
Generative AI Applications
Jun 17, 2024
Product updates
Runway launches Gen-3 Alpha for generating video clips
Generative AI Applications
Jun 17, 2024
Product updates
Adobe integrates Firefly into Acrobat with chat support across multiple documents in Acrobat AI Assistant
Generative AI Applications
Jun 17, 2024
Funding
Amplify Life raises USD 20 million in Series B to expand product suite
InsurTech: Personal Lines
Jun 17, 2024
Funding
Tinybird raises USD 30 million in Series B funding to improve real-time data analytics platform
Data Infrastructure & Analytics
Jun 17, 2024
Partnerships
The EVERY Company collaborates with Grupo Palacios to develop hen-less omelets
Plant-based Dairy & Egg
Jun 17, 2024
Partnerships
Believer Meats partners with AGWA to propel cultivated meat industry in MENA region
Cell-cultured Meat
Jun 17, 2024
Clinical Trial Technology

Clinical Trial Technology

Jun 2, 2024

Massive Bio and Mika Health partner to expand psycho-oncology and clinical trial services across US and Europe

Partnerships

  • Massive Bio and Mika Health have partnered to enhance patient access to psycho-oncology services, biomarker testing, and clinical trials.

  • The partnership expects to expand patients’ access to Mika’s Digital Therapeutic for treating oncology-related fatigue, anxiety, and depression. Subsequently, patients using Digital Therapeutic can opt into Massive Bio’s clinical trial matching and biomarker testing service, while Mika’s Digital Therapy will be available to Massive Bio's cancer patient registry. By leveraging AI-powered data-driven insights, the companies aim to provide personalized psychotherapy, symptom management, side-effect interception, and educational resources to their patients.

  • Mika Health, also known as Fosanis, is a digital health company headquartered in Germany that specializes in providing AI-powered precision medicine solutions designed to support cancer patients through the treatment process. The company’s proprietary "Mika" app offers a range of services, including symptom tracking, personalized guidance, and practical advice on managing cancer-related physical and emotional challenges.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.